Companies / Ideaya Biosciences, Inc.

Ideaya Biosciences, Inc.

Nasdaq: IDYACIK 1676725SOUTH SAN FRANCISCO, CAideayabio.com ↗

Financials · FY2025

Revenue$218.71M
Net income$-113.70M
Total debt—
Cash$272.59M
Diluted EPS$-1.28
Shares outstanding96.5M

Ownership

96.5M shares outstanding · as of Jul 31, 2026
0.09%Insiders
Ownership
Insiders0.09%82,827
Institutions98.58%95,120,503
Public float1.33%1,286,154

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Stein JeffreyDirector
0.06%54,281
Ruiz Briseno AndresSee Remarks
0.03%26,466
Snyder Douglas B.SVP, General Counsel
<0.01%2,080
Beaupre DarrinChief Medical Officer
——
Bleharski JoshuaChief Financial Officer
——
Dorman StuartFormerChief Commercial Officer
——
Hata Yujiro SCEOPresident and CEO · Director
——
Rosen Terry JDirector
——
White Michael AnthonyFormerChief Scientific Officer
——
Yarno Wendy LDirector
——

Institutional holders 250

View all →
HolderValue% of shares
Fmr LLC$454.59M13.63%
BlackRock, Inc.$331.45M9.22%
Janus Henderson Group PLC$242.02M7.53%
Capital Research Global Investors$182.52M5.47%
Vanguard Group Inc$173.52M5.20%
State Street Corporation$169.54M4.71%
Baker Bros. Advisors LP$131.50M4.09%
Logos Global Management LP$108.03M3.24%
Federated Hermes Inc$99.53M3.10%
Adage Capital Partners Gp, L.L.C.$94.08M2.93%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 2, 2026Stein Jeffrey
Director
BuyCommon Stock$1.65M+50K
+1167.95%
54,281
0.06% of shares
high
Nov 28, 2025Ruiz Briseno Andres
Executive
GrantCommon Stock$21.2K+1K
+4.97%
26,466
0.03% of shares
low
Nov 28, 2025Snyder Douglas B.
Executive
GrantCommon Stock$17.6K+1K
+100.19%
2,080
<0.01% of shares
low
May 30, 2025Snyder Douglas B.
Executive
GrantCommon Stock$17.6K+1K
1,039
<0.01% of shares
low
Nov 29, 2024Ruiz Briseno Andres
Executive
GrantCommon Stock$15.9K+682
+2.78%
25,213
0.03% of shares
low
Jun 16, 2026Rosen Terry J
Director
GrantStock Option (right to buy)—+20K
20,000
0.02% of shares
low
Jun 16, 2026Yarno Wendy L
Director
GrantStock Option (right to buy)—+20K
20,000
0.02% of shares
low
Jan 30, 2026Snyder Douglas B.
Executive
GrantStock Option (right to buy)—+130K
130,000
0.13% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Federated Hermes IncPassive13G/A———
Capital Research Global InvestorsPassive13G/A———
Point72 Asset Management, L.P.Passive13G/A———
Janus Henderson Group PLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IDYA——45166A102—